Health Care Sector Update for 06/08/2018: ALNY, NVS, MYOV, BTX, TROV

Shutterstock photo

Top Health Care stocks:

JNJ: -0.03%

PFE: +0.1%

ABT: flat

MRK: -0.1%

AMGN: flat

Health care shares were lower ahead of the bell on Friday.

Expected movers:

- Alnylam Pharmaceuticals ( ALNY ): reported positive results from its phase 1/2 clinical trial of its drug lumasiran to treat primary hyperoxaluria type 1

- Novartis AG ( NVS ): reported data from a phase 3 trial showed that treatment with Lutathera provided significantly longer time to deterioration of quality of life for patients with progressive midgut Neuroendocrine tumors

- Myovant Sciences ( MYOV ): reports wider Q4 loss from prior year, misses estimates

Other news:

- BioTime ( BTX ): to distribute some or all of its equity stake in a subsidiary, AgeX Therapeutics, Inc., to the company's shareholders on a pro-rata basis

- TrovaGene ( TROV ): priced an underwritten public offering of 18 million shares and warrants at $1 per share

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , US Markets
Referenced Symbols: ALNY , NVS , MYOV , BTX , TROV

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities

Research Brokers before you trade

Want to trade FX?